CMO Scorecard – Outsourcing of NDA Approvals and CMO Performance – 2019 PharmSource Edition

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

This report is the 9th edition of our long running analysis of the CMO Industry, using NDA approvals as the primary indicator of performance. CMO Scorecard is critical for benchmarking the performance of the CMO industry and the relative performance of major CMOs.

Scope

Who should buy this report?

This 50-page report gives important, expert insight you won’t find in any other source. 32 tables and figures throughout the report illustrate major points and trends. This report is required reading for:

• CMO executives who must have deep understanding of the injectables marketplace to make strategic planning and investment decisions.

• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.

• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

Overview of NDA drug approvals and the levels of outsourcing associated with NDA sub segments

Detailed view of CDMO performance by number of approvals and an assessment of their sponsors market caps from the PharmSource Contract Service Providers database

Outsourcing propensity for NMEs, different dosage forms and by sponsor company cap have all been assessed.

Analysis of NME special products approvals such as those with Orphan, Breakthrough or Fast Track designations and assessment of outsourcing

3M Drug Delivery Systems
AbbVie Inc
ABF Pharmaceutical Services GmbH
ACS Dobfar SPA
Adare Pharmaceuticals Inc
Adoh BV
Aenova Holding GmbH
Aesica Pharmaceuticals Ltd
Afton Scientific Corp
Ajinomoto Althea Inc
Ajinomoto Co Inc
Akorn Inc
Albany Molecular Research Inc
Alcami Corp
Alkermes Plc
Allergan Plc
Alliance Contract Pharma LLC
Almac Group Ltd
Alpex Pharma SA
Apotex Inc
Aquestive Therapeutics Inc
ARx LLC
ASM - Aerosol-Service AG
AstraZeneca Plc
AustarPharma LLC
Avara Pharmaceutical Services Inc
Bausch & Lomb Pharmaceuticals Inc
Bausch Health Companies
Baxter Biopharma Solutions
Bayer AG
BioRamo LLC
Boehringer Ingelheim Bioxcellence
Boehringer Ingelheim GmbH
Cadila Healthcare Ltd
Capsugel Inc
Catalent Inc
Cenexi SAS
Centre for Probe Development and Commercialization
Cerovene Inc
Cipla Ltd
Confab Laboratories Inc
Contract Pharmaceuticals Ltd
Delpharm SAS
Dexcel PT Israel Ltd
DPT Laboratories Ltd
Ei A Pharmaceutical SolutionWorks (TM)
Eisai Co Ltd
Emergent BioSolutions Inc
Excella GmbH & Co KG
Exela Pharma Sciences LLC
Fareva SA
Fresenius Kabi Product Partnering
Fritz Keller Holding AG
Galephar Pharmaceutical Research Inc
Gilead Sciences Inc
Gland Pharma Ltd
GlaxoSmithKline Plc
Glenmark Pharmaceuticals Ltd
Grifols SA
Groupe Synerlab SAS
Grunenthal GmbH
Halo Pharma Inc
Hameln Pharmaceuticals GmbH
Hikma Pharmaceuticals Plc
Holopack Verpackungstechnik GmbH
Hovione FarmaCiencia SA
Importfab Inc
Institutt for Energiteknikk
Insud Pharma
Intas Pharmaceuticals Ltd
James Alexander Corp.
Jubilant HollisterStier Contract Manufacturing & Services
Kemwell Biopharma Pvt Ltd
KP Pharmaceutical Technology Inc
Kyowa Hakko Kirin Co Ltd
Laboratoires PANPHARMA SA
Laboratoires Pierre Fabre SA
Laboratoires Thea SA
Lifecore Biomedical LLC
LTS Lohmann Therapie-Systeme AG
Lyne Laboratories
Lyophilization Services of New England Inc
Merck & Co Inc
Mikart Inc
Mipharm SpA
Mitsubishi Tanabe Pharma Corp
Mylan NV
Napp Pharmaceuticals Ltd
Neolpharma SA De CV
Nexgen Pharma Inc
NextPharma Technologies Holding Ltd
Nordmark Arzneimittel GmbH & Co KG
Norwich Pharma Services
Novast Holdings Ltd
Nuvo Pharmaceuticals Inc
OishiKoseido Corp
Orion Corp
OSO BioPharmaceuticals Manufacturing LLC
Paras Biopharmaceuticals Finland Oy
PARI Pharma GmbH
Patheon NV
PCI Pharma Services
Perrigo Co Plc
Pfizer Inc
Pharmaceutical Manufacturing Research Services Inc
Pharmaceutics International Inc
Pharmascience Inc Pharmasol Corp
Pierrel Spa
Pillar5 Pharma Inc
Propak Health Ltd
QPharma AB
Quotient Sciences Ltd
Rechon Life Science AB
Recipharm AB
Recro Pharma Inc
Renaissance Pharma Inc
Rentschler Biotechnologie GmbH
Rivopharm SA
Rosemont Pharmaceuticals Ltd
Rottendorf Pharma GmbH
Sanico NV
Sanofi
Sharp Packaging Services
Shire Plc
Siegfried Holding AG
Sintetica SA
Sirton Pharmaceuticals SpA
Sterigenics International
Steri-Pharma LLC
Synergy Health Ltd
Tapemark Co
Teligent Inc
Teva Pharmaceutical Industries Ltd
The Ritedose Corp
Therapure Biopharma Inc
Torii Pharmaceutical Co Ltd
Tris Pharma Inc
UCB SA
Unither Pharmaceuticals
University of Iowa Pharmaceuticals
UPM Pharmaceuticals Inc
USV Pvt Ltd
Vectura Group Plc
Vetter Pharma-Fertigung GmbH & Co KG
Vianex SA
Vifor Pharma AG
Woodfield Pharmaceutical LLC
Zymeworks Inc

Table of Contents

1 Table of Contents 2

2 List of Tables 3

3 List of Figures 3

4 Executive Summary 4

5 Introduction 5

6 NDA Approvals Overview 5

7 US vs. EU Approval Performance 7

8 Outsourced Dose Manufacture 8

9 Special Product Categories 14

10 Outsourcing by Mega Cap Companies 19

11 CMO Performance 20

11.1 Catalent 26

11.2 Patheon 26

11.3 Other Prominent CMOs 26

12 Outsourced API Approvals 27

13 What it Means 28

13.1 Approvals Have Risen 28

13.2 Drivers for Outsourcing 30

13.2.1 Niche Technology 31

13.2.2 Small Volumes, Special Designations 31

14 Notes on Methodology 33

15 Appendix 34

15.1 Appendix Tables 34

15.2 Bibliography 46

15.3 Primary Research – Key Opinion Leaders in this Report 47

15.4 About the Authors 48

15.5 Contact Us 50

15.6 Disclaimer 50

Table

Table 1: Outsourced NDA Approvals by Dosage Form 12

Table 2: Outsourcing by Sponsor Market Cap and FDA Approval Type, 2012–2018 13

Table 3: API CMOs Receiving NME Approvals in 2018 28

Table 4: 2018 CBER Approvals Included in the Analysis 34

Table 5: 2018 Outsourced Dose Approvals 35

Table 6: Dose CMOs Receiving Contracts for FDA Approvals in 2009–2018 38

Table 7: API CMOs Receiving NME Approvals in 2018 42

Table 8: Dose CMOs’ Manufacturing NDAs Approved in 2018 44

Table 9: MHRA Approvals in 2018 45

Figures

Figure 1: NDA and BLA Approvals 2009–2018 6

Figure 2: NDA Approvals by Sponsor Type, 2009–2018 7

Figure 3: EMA Approvals, 2012–2018 8

Figure 4: Share of NDA Approvals Outsourced 2009–2018 9

Figure 5: NDA Approvals Outsourced 2009–2018 10

Figure 6: Dose Outsourcing of Small Molecule and Biologic NMEs 2009–2018 11

Figure 7: Outsourcing of NME Approvals by Sponsor Market Cap 13

Figure 8: Outsourcing of Non-NME NDA Approvals by Sponsor Market Cap 14

Figure 9: Outsourcing of Orphan NMEs 2009–2018 15

Figure 10: Outsourcing of Fast Track NMEs 2011–2018 16

Figure 11: Outsourcing of Breakthrough Therapy Designation NMEs, 2013–2018 17

Figure 12: NMEs Requiring Special Handling 2008–2018 18

Figure 13: Approval and Outsourcing of NMEs Utilizing Solubility Enhancement 2011-2018 19

Figure 14: Mega Cap Outsourcing Propensity 2008–2018 20

Figure 15: Breakdown in Composition of Outsourced NMEs, by Sponsor Market Cap, 2008–2018 21

Figure 16: Breakdown in Composition of Outsourced Non-NME NDAs, by Sponsor Market Cap, 2008–2018 22

Figure 17: CMO Market Share of Parenteral NME Approvals, 2009–2018 23

Figure 18: CMO Market Share of Parenteral Non-NME NDA Approvals, 2009–2018 24

Figure 19: CMO Market Share of Solid NME Approvals, 2009–2018 25

Figure 20: CMO Market Share of Solid Non-NME NDA Approvals, 2009–2018 25

Figure 21: API Outsourcing of Chemical and Biologic NMEs, 2008–2018 27

Figure 22: Innovator Drug Clinical Trials Versus FDA NDA/BLA Approvals, 2009–2018 29

Figure 23: ANDA Approvals 2009–2018 46

Frequently asked questions

CMO Scorecard – Outsourcing of NDA Approvals and CMO Performance – 2019 PharmSource Edition thematic reports
Currency USD
$4,995

Can be used by individual purchaser only

$14,985

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

CMO Scorecard – Outsourcing of NDA Approvals and CMO Performance – 2019 PharmSource Edition was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at CMO Scorecard – Outsourcing of NDA Approvals and CMO Performance – 2019 PharmSource Edition in real time.

  • Access a live CMO Scorecard – Outsourcing of NDA Approvals and CMO Performance – 2019 PharmSource Edition dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.